Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2022-000902
Request Summary: Adverse Drug Reactions (ADRs) for Pantoprazole sodium. Report numbers: E2B_05566840, E2B_05589438, E2B_05575121, E2B_05591402, E2B_05552008. ADRs for Mesalazine. Report numbers: E2B_05530426, E2B_05557453, E2B_05596202, E2B_05554526. ADR for Mesalamine. Report number: E2B_05597393.
Disposition: Disclosed in part
Number of pages: 1022